mesowatch-logo
J&J Talc Settlement State by State
divider

Breaking Down the J&J Talc Settlement by State: Who Gets What?

Breaking Down the J&J Talc Settlement by State: Who Gets What?

John Edwards

Reading Time: 6 mins

Published On: June 28, 2024

John Edwards - author

John Edwards Is a husband, father, veteran and medical writer, from the state of California. After serving 9 years in the U.S Army Medical Department, John cultivated his passion for serving his country and helping people. He often volunteers with helping to rehabilitate veterans of all ages. After John’s father was diagnosed with Mesothelioma, he began to research, write and fight for ways to help other victims of asbestos exposure.

More to Read

divider

June 26, 2024

Study Confirms Ki67 Predicts Mesothelioma Treatment Success

>READ

divider

June 18, 2024

Lawsuit Seeks Justice for Women at Risk from J&J Talc Powder

>READ

divider

June 13, 2024

Cancer Victims Motion Judge to Block J&J’s Bankruptcy Settlement

>READ

divider

June 12, 2024

ADAO Gains Support in Fight for Broader EPA Asbestos Ban

>READ

divider

June 11, 2024

J&J Agrees to Settle Consumer Deception Claims for $700 Million

>READ

divider

June 11, 2024

J&J Faces New Mesothelioma Trial in Texas Over Talc Claims

>READ

divider

Want to Contribute Breaking News?

To contribute to our constant feed of relevant legal matters

News & Data

divider

FILTER:

search
divider
Promising Immunotherapy Case for Peritoneal Mesothelioma
Promising Immunotherapy Case for Peritoneal Mesothelioma

Mary Pieper
2 mins read - July 5, 2024

Frontiers in Oncology provisionally accepted a case report Friday suggesting the use of first-line nivolumab and ipilimumab could be more effective than chemotherapy in malignant...

Treatment

Judge Rejects J&J’s Fraud Allegations in Mesothelioma Talc Study Case
Judge Rejects J&J’s Fraud Allegations in Mesothelioma Talc Study Case

Mary Pieper
4 mins read - July 2, 2024

A scientist has scored a victory over Johnson & Johnson, which alleged her influential research linking asbestos-contaminated cosmetic products to the deadly cancer...

Settlements

Judge Dismisses Bid to Block J&J’s $6.48B Talc Settlement
Judge Dismisses Bid to Block J&J’s $6.48B Talc Settlement

Melissa Bill
4 mins read - July 1, 2024

On June 28, a federal judge rejected a preliminary order by cancer victims aimed at blocking Johnson & Johnson from moving forward on its proposed  $6.48 billion...

Settlements

Study Confirms Ki67 Predicts Mesothelioma Treatment Success
Study Confirms Ki67 Predicts Mesothelioma Treatment Success

Mary Pieper
3 mins read - June 26, 2024

The results of an international study indicate that the expression of the nuclear protein Ki67 in the tumors of pleural mesothelioma patients can not only gauge the aggressiveness...

Research

Lawsuit Seeks Justice for Women at Risk from J&J Talc Powder
Lawsuit Seeks Justice for Women at Risk from J&J Talc Powder

Mary Pieper
3 mins read - June 18, 2024

Women who are at risk for ovarian or fallopian tube cancer due to prolonged use of Johnson & Johnson’s talc powder products could benefit from court-supervised health...

Settlements

Cancer Victims Motion Judge to Block J&J’s Bankruptcy Settlement
Cancer Victims Motion Judge to Block J&J’s Bankruptcy Settlement

Melissa Bill
3 mins read - June 13, 2024

Lawyers for talc claimants filed a motion on Tuesday in a New Jersey court, seeking to prevent a planned third J&J bankruptcy from being filed in Texas or any other...

Settlements


June 12, 2024

ADAO Gains Support in Fight for Broader EPA Asbestos Ban

>READ

divider

June 11, 2024

J&J Agrees to Settle Consumer Deception Claims for $700 Million

>READ

divider

June 11, 2024

J&J Faces New Mesothelioma Trial in Texas Over Talc Claims

>READ

divider

June 5, 2024

J&J and Beasley Allen Clash Over $6.48 Billion Talc Settlement

>READ

divider

June 4, 2024

Historic $260M Verdict Against J&J in Asbestos-Tainted Talc Case

>READ

divider

June 3, 2024

Early RSO-021 Clinical Trial Provides Hope for Mesothelioma Patients

>READ

divider

June 2, 2024

Women File Class Action Suit Over J&J’s Attempts to Evade Talc Claims

>READ

divider

May 30, 2024

FDA Prioritizes Keytruda-Chemo Combo for Mesothelioma Patients

>READ

divider

May 28, 2024

Study Favors Chemo Over Surgery in Malignant Pleural Mesothelioma

>READ

divider

Browse Categories

divider

Want to Contribute Breaking News?

To contribute to our constant feed of relevant legal matters

Information provided by Mesowatch aims to provide legal and financial assistance and should not be considered a substitute for medical advice, treatment or diagnosis. Past performance and settlements do not guarantee or indicate the outcome of an individual case. Viewing this information or interacting with this website does not create an attorney-client relationship. DMCA.com Protection Status